This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Celine Dion, Caesars Entertainment And AEG Live Raise $1 Million With Special Performance Benefitting The Cystic Fibrosis Foundation

LAS VEGAS, Jan. 21, 2013 /PRNewswire/ -- The Cystic Fibrosis Foundation is one step closer to finding a cure for cystic fibrosis thanks to a little help from some superstar friends.  More than $1 million was raised in support of cystic fibrosis research efforts last night during a special performance " Adding Tomorrows with Celine Dion," a partnership with international music icon Celine Dion, Caesars Entertainment, AEG Live and the Cystic Fibrosis Foundation.  Held at Caesars Palace, the evening included a performance of Celine Dion's glamorous show by Grammy Awards producer Ken Ehrlich and featured a touching tribute to those with cystic fibrosis during her rendition of Billy Joel's "Lullabye."

Funds from the benefit concert will support critical research for cystic fibrosis, a fatal genetic disease that causes debilitating lung infections and premature death. As the world's leading organization fighting cystic fibrosis, the CF Foundation funds more research than any other organization and is fueling tremendous advances toward a cure and improving the lives of those with the disease.

Celine lost her niece Karine to cystic fibrosis in 1993 and has been involved in the fight against this disease as the Celebrity Patron for Cystic Fibrosis Canada since 1982.

"The cystic fibrosis cause holds a very special place in my heart and I'm honored to have been able to team up with the Cystic Fibrosis Foundation, my partners at Caesars Entertainment and AEG Live to help raise funds and awareness for this worthy cause," said Celine. "We're making dramatic progress in treating this terrible disease, and I truly hope that one day soon, CF will stand for 'cure found.'"

Prior to Celine's benefit performance guests who purchased special VIP packages were treated to an exclusive welcome reception and group photo with Celine during her pre-concert sound check, dinner at Old Homestead Steakhouse and admission to a private post-concert reception at Gordon Ramsay Pub & Grill sponsored by Southern Wine & Spirits. 

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs